About
Monoclonal Antibody Therapies
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibodySan Diego & Southern California
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
7
As Collaborator
0
Total Enrollment
294
By Phase
PHASE2: 2PHASE3: 2PHASE1: 2PHASE1/PHASE2: 1
By Status
COMPLETED: 4WITHDRAWN: 2TERMINATED: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05589610Lead Sponsor
Study of EQ101 in Adult Subjects With Moderate to Severe Alopecia Areata
PHASE2Completed
36 participants
Started: Dec 19, 2022 · Completed: Apr 30, 2024
NCT05263999Lead Sponsor
A Study of Itolizumab in Combination With Corticosteroids for the First-Line Treatment of Acute Graft Versus Host Disease (EQUATOR)
PHASE3Terminated
158 participants
Started: Apr 29, 2022 · Completed: May 12, 2025
NCT03532958Lead Sponsor
Phase 2 Trial of BNZ-1 in Patients With Moderate to Severe Alopecia Areata
PHASE2Withdrawn
Started: Oct 31, 2021 · Completed: Nov 30, 2022
NCT04605926Lead Sponsor
A Study to Evaluate the Efficacy and Safety of Itolizumab in Subjects Hospitalized With COVID-19
PHASE3Withdrawn
Started: Nov 30, 2020 · Completed: Jun 30, 2021
NCT04128579Lead Sponsor
Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis
PHASE1Completed
52 participants
Started: Oct 1, 2019 · Completed: Jan 18, 2024
Locations (1)
Headquarters
La Jolla, CA, United States
Map
Loading map...